Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Expects To Save $900 Mil. By FY 2004 In $1.9 Bil. Restructuring Effort

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble expects to record annual after-tax cost savings of $900 mil. by fiscal 2004 under the latest phase of the company's Organization 2005 restructuring program, CEO Durk Jager announced June 9. Savings over the next fiscal year are not expected to be significant, but P&G said it will "ramp up" the program through FY 2004.

You may also be interested in...



P&G Restructuring Program Early Termination Slated For Mid-2003

Procter & Gamble expects to record after-tax savings of $1.4 bil.-$1.5 bil. by the end of its current fiscal year on June 30, when it plans to brings its restructuring efforts to a close

P&G Restructuring Program Early Termination Slated For Mid-2003

Procter & Gamble expects to record after-tax savings of $1.4 bil.-$1.5 bil. by the end of its current fiscal year on June 30, when it plans to brings its restructuring efforts to a close

P&G Restructuring Initiatives To Save $1.9 Bil. By FY 2004

Procter & Gamble will save $500 mil.-$600 mil. by the end of fiscal 2002 (June 30, 2002) with implementation of the second phase of its Organization 2005 restructuring program, President & CEO A.G. Lafley predicted in a teleconference with analysts March 22.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel